跳至主要内容
临床试验/NCT01966380
NCT01966380终止2 期

An Open Randomised, Prospective, Crossover, Proof of Concept (Design Validation) Clinical Investigation to Caompare the Performance and Safety of Wound Dressing(Leia) Compared to and Hydroactive Surgical Dressing on Low to Highly Exuding Wounds

Molnlycke Health Care AB2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
发起方
入组人数
6
试验地点
2
主要终点
Absorption of Wound Exudates.

研究概览

简要总结

The purpose of this reseach study is to determine Mölnlycke Health Care´s Leia dressing performance properties is fulfilled and that the dressing is safe when used on wound types such as pressure ulcer, leg ulcer, and diabetic foot ulcer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Low to highly exuding chronic wound(wound history > 2 months) such as Leg Ulcer, Pressure Ulcer Category III to IV or Diabetic Foot Ulcer
  • Male of female, 18 years and above
  • Signed Informed Consent Form

排除标准

  • Pregnancy or lactation
  • Wound size not suitable for the wound dressing size
  • Known allergy/hypersensitivity to any of the components in the dressing

研究组 & 干预措施

Device, dressing

Experimental

Intervention: Device, Leia dressing

干预措施: Leia (Device)

Dressing , device

Active Comparator

Intervention: Device: Hydroactive surgical dressing

干预措施: Leia (Device)

结局指标

主要结局

Absorption of Wound Exudates.

时间窗: 2-3 weeks

Absorption capacity measured subjectively: NA/POOR/GOOD/VERY GOOD/EXCELLENT

次要结局

未报告次要终点

研究者

发起方
Molnlycke Health Care AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Proof of Concept (Design Validation) in Patient With... | 临床试验